HANGZHOU CATALYZ PHARMACEUTICAL CO., LTD

Grubbs Catalyst 1st Generation **********9 Grubbs Catalyst 2nd Generation **********3 Hoveyda-Grubbs Catalyst 1st Generation **********0 Hoveyda-Grubbs Catalyst 2nd Generation **********8 (R)-BINAP *********4 (S)-BINAP Rac-BINAP *********8 (R)-TolBINAP *********3 (S)-TolBINAP **********6 (R)-(+)*2, 2'-Bis[di(3, *-xylyl)phosphino]*1, 1'-binaphthyl **********4 (S)-XylBINAP **********3 (R)-H*-BINAP **********9 (S)-H*-BINAP The overriding goal of the Catalysis and Chiral Technologies (CCT) business unit of Johnson Matthey is to develop innovative products and technologies designed to optimize the catalytic solutions needed by our customers in the pharmaceutical and fine chemical sectors. We have a broad portfolio of advanced catalysts and ligands that we continually expand through our own R&D efforts and through collaborations with leading researchers in CatalyzPharma.